Skip to main content
Erschienen in: Virchows Archiv 1/2014

01.07.2014 | Original Article

Atypical spindle cell lipoma: a clinicopathologic, immunohistochemical, and molecular study emphasizing its relationship to classical spindle cell lipoma

verfasst von: David Creytens, Joost van Gorp, Suvi Savola, Liesbeth Ferdinande, Thomas Mentzel, Louis Libbrecht

Erschienen in: Virchows Archiv | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

We studied a series of spindle cell lipomas arising in atypical sites and showing unusual morphologic features (which we called atypical spindle cell lipoma) to assess if these lesions have the same chromosomal alterations as classical spindle cell lipoma but different from those found in atypical lipomatous tumor/well-differentiated liposarcoma. We investigated alterations of different genes in the 13q14 region and the amplification status of the MDM2 and CDK4 genes at 12q14-15 by multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH) analysis. In the atypical spindle cell lipomas, MLPA revealed deletions in the two nearest flanking genes of RB1 (ITM2B and RCBTB2) and in multiple important exons of RB1. In contrast, in classical spindle cell lipomas, a less complex loss of RB1 exons was found but no deletion of ITM2B and RCBTB2. Moreover, MLPA identified a deletion of the DLEU1 gene, a finding which has not been reported earlier. We propose an immunohistochemical panel for lipomatous tumors which comprises of MDM2, CDK4, p16, Rb, which we have found useful in discriminating between atypical or classical spindle cell lipomas and other adipocytic neoplasms, especially atypical lipomatous tumor/well-differentiated liposarcoma. Our findings strengthen the link between atypical spindle cell lipoma and classical spindle cell lipoma, and differentiate them from atypical lipomatous tumor/well-differentiated liposarcoma.
Literatur
1.
Zurück zum Zitat Mentzel T, Palmedo G, Kuhnen C (2010) Well-differentiated spindle cell liposarcoma (‘atypical spindle cell lipomatous tumor’) does not belong to the spectrum of atypical lipomatous tumor but has a close relationship to spindle cell lipoma: clinicopathologic, immunohistochemical, and molecular analysis of six cases. Mod Pathol 23:729–736PubMedCrossRef Mentzel T, Palmedo G, Kuhnen C (2010) Well-differentiated spindle cell liposarcoma (‘atypical spindle cell lipomatous tumor’) does not belong to the spectrum of atypical lipomatous tumor but has a close relationship to spindle cell lipoma: clinicopathologic, immunohistochemical, and molecular analysis of six cases. Mod Pathol 23:729–736PubMedCrossRef
2.
Zurück zum Zitat Dei Tos AP, Mentzel T, Newman PL et al (1994) Spindle cell liposarcoma, a hitherto unrecognized variant of liposarcoma. Analysis of six cases. Am J Surg Pathol 18:913–921PubMedCrossRef Dei Tos AP, Mentzel T, Newman PL et al (1994) Spindle cell liposarcoma, a hitherto unrecognized variant of liposarcoma. Analysis of six cases. Am J Surg Pathol 18:913–921PubMedCrossRef
3.
Zurück zum Zitat Mentzel T, Toenissen J, Rütten A et al (2005) Palmar atypical lipomatous tumour with spindle cell features (well-differentiated spindle cell liposarcoma): a rare neoplasm arising in an unusual anatomical location. Virchows Arch 446:300–304PubMedCrossRef Mentzel T, Toenissen J, Rütten A et al (2005) Palmar atypical lipomatous tumour with spindle cell features (well-differentiated spindle cell liposarcoma): a rare neoplasm arising in an unusual anatomical location. Virchows Arch 446:300–304PubMedCrossRef
4.
Zurück zum Zitat Agostini T, Catelani C, Acocella A et al (2010) Spindle cell liposarcoma of the face: case report and literature review. Br J Dermatol 163:638–640PubMedCrossRef Agostini T, Catelani C, Acocella A et al (2010) Spindle cell liposarcoma of the face: case report and literature review. Br J Dermatol 163:638–640PubMedCrossRef
5.
Zurück zum Zitat Rajasekhar C, Paul AS, Bale RS (2005) Spindle-cell liposarcoma: a rare variant of liposarcoma arising in the foot. Clin Oncol (R Coll Radiol) 17:128–129CrossRef Rajasekhar C, Paul AS, Bale RS (2005) Spindle-cell liposarcoma: a rare variant of liposarcoma arising in the foot. Clin Oncol (R Coll Radiol) 17:128–129CrossRef
6.
Zurück zum Zitat Cai YC, McMenamin ME, Rose G et al (2001) Primary liposarcoma of the orbit: a clinicopathologic study of seven cases. Ann Diagn Pathol 5:255–266PubMedCrossRef Cai YC, McMenamin ME, Rose G et al (2001) Primary liposarcoma of the orbit: a clinicopathologic study of seven cases. Ann Diagn Pathol 5:255–266PubMedCrossRef
7.
Zurück zum Zitat Shioi Y, Hasegawa T, Otsuka K et al (2010) Primary retroperitoneal spindle cell liposarcoma: pathological and immunohistochemical findings. Pathol Int 60:472–476PubMedCrossRef Shioi Y, Hasegawa T, Otsuka K et al (2010) Primary retroperitoneal spindle cell liposarcoma: pathological and immunohistochemical findings. Pathol Int 60:472–476PubMedCrossRef
8.
Zurück zum Zitat Allagio R, Coffin CM, Weiss SW et al (2009) Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age. Am J Surg Pathol 33:645–658CrossRef Allagio R, Coffin CM, Weiss SW et al (2009) Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age. Am J Surg Pathol 33:645–658CrossRef
9.
Zurück zum Zitat Nascimento AF, Fletcher CDM (2005) Spindle cell liposarcoma/atypical lipomatous tumor. A clinicopathologic study of 120 cases. Mod Pathol 8:70A Nascimento AF, Fletcher CDM (2005) Spindle cell liposarcoma/atypical lipomatous tumor. A clinicopathologic study of 120 cases. Mod Pathol 8:70A
10.
Zurück zum Zitat Italiano A, Chambonniere M-L, Attias R et al (2008) Monosomy 7 and absence of 12q amplification in two cases of spindle cell liposarcomas. Cancer Genet Cytogenet 184:99–104PubMedCrossRef Italiano A, Chambonniere M-L, Attias R et al (2008) Monosomy 7 and absence of 12q amplification in two cases of spindle cell liposarcomas. Cancer Genet Cytogenet 184:99–104PubMedCrossRef
11.
Zurück zum Zitat Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F (2013) World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of Soft Tissue and Bone. IARC, Lyon Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F (2013) World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of Soft Tissue and Bone. IARC, Lyon
13.
Zurück zum Zitat Buiting K, Kanber D, Horsthemke B et al (2010) Imprinting of RB1 (the new kid on the block). Brief Funct Genomics 9:347–353PubMedCrossRef Buiting K, Kanber D, Horsthemke B et al (2010) Imprinting of RB1 (the new kid on the block). Brief Funct Genomics 9:347–353PubMedCrossRef
15.
Zurück zum Zitat Dal Cin P, Sciot R, Polito P et al (1997) Lesions of 13q may occur independently of deletion of 16q in spindle cell/pleiomorphic lipomas. Histopathology 31:222–225PubMedCrossRef Dal Cin P, Sciot R, Polito P et al (1997) Lesions of 13q may occur independently of deletion of 16q in spindle cell/pleiomorphic lipomas. Histopathology 31:222–225PubMedCrossRef
16.
Zurück zum Zitat Bartuma H, Nord KH, Macchia G et al (2011) Gene expression and single nucleotide polymorphism array analyses of spindle cell lipomas and conventional lipomas with 13q14 deletion. Genes Chromosomes Cancer 50:619–632PubMedCrossRef Bartuma H, Nord KH, Macchia G et al (2011) Gene expression and single nucleotide polymorphism array analyses of spindle cell lipomas and conventional lipomas with 13q14 deletion. Genes Chromosomes Cancer 50:619–632PubMedCrossRef
17.
Zurück zum Zitat Maggiani F, Debiec-Rychter M, Verbeeck G et al (2006) Extramammary myofibroblastoma is genetically related to spindle cell lipoma. Virchows Arch 449:244–247PubMedCrossRef Maggiani F, Debiec-Rychter M, Verbeeck G et al (2006) Extramammary myofibroblastoma is genetically related to spindle cell lipoma. Virchows Arch 449:244–247PubMedCrossRef
18.
Zurück zum Zitat Pauwels P, Sciot R, Croiset F et al (2000) Myofibroblastoma of the breast: genetic link with spindle cell lipoma. J Pathol 19:1282–1285 Pauwels P, Sciot R, Croiset F et al (2000) Myofibroblastoma of the breast: genetic link with spindle cell lipoma. J Pathol 19:1282–1285
19.
Zurück zum Zitat Flucke U, Van Krieken JHJM, Mentzel T (2011) Cellular angiofibroma: analysis of 25 cases emphasizing its relationship to spindle cell lipoma and mammary-type myofibroblastoma. Mod Pathol 24:82–89PubMedCrossRef Flucke U, Van Krieken JHJM, Mentzel T (2011) Cellular angiofibroma: analysis of 25 cases emphasizing its relationship to spindle cell lipoma and mammary-type myofibroblastoma. Mod Pathol 24:82–89PubMedCrossRef
20.
Zurück zum Zitat Fritchie KJ, Carver P, Sun Y et al (2012) Solitary fibrous tumor. Is there a molecular relationship with cellular angiofibroma, spindle cell lipoma, and mammary-type myofibroblastoma? Am J Clin Pathol 137:963–970PubMedCrossRef Fritchie KJ, Carver P, Sun Y et al (2012) Solitary fibrous tumor. Is there a molecular relationship with cellular angiofibroma, spindle cell lipoma, and mammary-type myofibroblastoma? Am J Clin Pathol 137:963–970PubMedCrossRef
21.
Zurück zum Zitat Magro G, Righi A, Casorzo L et al (2012) Mammary and vaginal myofibroblastomas are genetically related lesions: fluorescence in situ hybridization analysis shows deletion of 13q14 region. Hum Pathol 43:1887–1893PubMedCrossRef Magro G, Righi A, Casorzo L et al (2012) Mammary and vaginal myofibroblastomas are genetically related lesions: fluorescence in situ hybridization analysis shows deletion of 13q14 region. Hum Pathol 43:1887–1893PubMedCrossRef
22.
Zurück zum Zitat Chen BJ, Marino-Enriquez A, Fletcher CDM et al (2012) Loss of retinoblastoma protein expression in spindle cell/pleomorphic lipomas and cytogenetically related tumors: an immunohistochemical study with diagnostic implications. Am J Surg Pathol 36:1119–1128PubMedCrossRef Chen BJ, Marino-Enriquez A, Fletcher CDM et al (2012) Loss of retinoblastoma protein expression in spindle cell/pleomorphic lipomas and cytogenetically related tumors: an immunohistochemical study with diagnostic implications. Am J Surg Pathol 36:1119–1128PubMedCrossRef
23.
Zurück zum Zitat Thway K, Flora R, Shah C et al (2012) Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors. Am J Surg Pathol 36:462–469PubMedCrossRef Thway K, Flora R, Shah C et al (2012) Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors. Am J Surg Pathol 36:462–469PubMedCrossRef
24.
Zurück zum Zitat Gonzalez RS, McClain CM, Chamberlain BK et al (2013) Cyclin-dependent kinase inhibitor 2A (p16) distinguishes well-differentiated liposarcoma from lipoma. Histopathology 62:1109–1111PubMedCrossRef Gonzalez RS, McClain CM, Chamberlain BK et al (2013) Cyclin-dependent kinase inhibitor 2A (p16) distinguishes well-differentiated liposarcoma from lipoma. Histopathology 62:1109–1111PubMedCrossRef
25.
Zurück zum Zitat Rocco JW, Sidransky D (2001) p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 264:42–55PubMedCrossRef Rocco JW, Sidransky D (2001) p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 264:42–55PubMedCrossRef
26.
Zurück zum Zitat Cance WG, Brennan MF, Dudas ME et al (1990) Altered expression of the retinoblastoma gene product in human sarcomas. N Engl J Med 323:1457–1462PubMedCrossRef Cance WG, Brennan MF, Dudas ME et al (1990) Altered expression of the retinoblastoma gene product in human sarcomas. N Engl J Med 323:1457–1462PubMedCrossRef
27.
Zurück zum Zitat Karpeh MS, Brennan MF, Cance WG et al (1995) Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas. Br J Cancer 72:986–991PubMedCentralPubMedCrossRef Karpeh MS, Brennan MF, Cance WG et al (1995) Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas. Br J Cancer 72:986–991PubMedCentralPubMedCrossRef
28.
Zurück zum Zitat Cohen JA, Geradts J (1997) Loss of RB and MTS1/CDKN2 (p16) expression in human sarcomas. Hum Pathol 28:893–898PubMedCrossRef Cohen JA, Geradts J (1997) Loss of RB and MTS1/CDKN2 (p16) expression in human sarcomas. Hum Pathol 28:893–898PubMedCrossRef
29.
Zurück zum Zitat He M, Aisner S, Benevenia J et al (2009) P16 immunohistochemistry as an alternative marker to distinguish atypical lipomatous tumor from deep-seated lipoma. Appl Immunohistochem Mol Morphol 17:51–56PubMedCrossRef He M, Aisner S, Benevenia J et al (2009) P16 immunohistochemistry as an alternative marker to distinguish atypical lipomatous tumor from deep-seated lipoma. Appl Immunohistochem Mol Morphol 17:51–56PubMedCrossRef
30.
Zurück zum Zitat Binh MBG, Sastre-Garau X, Guillou L et al (2005) MDM2 and CDK4 immunostains are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes. Am J Surg Pathol 29:1340–1347PubMedCrossRef Binh MBG, Sastre-Garau X, Guillou L et al (2005) MDM2 and CDK4 immunostains are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes. Am J Surg Pathol 29:1340–1347PubMedCrossRef
31.
Zurück zum Zitat Weaver J, Downs-Kelly E, Goldblum JR et al (2008) Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Mod Pathol 21:943–949PubMedCrossRef Weaver J, Downs-Kelly E, Goldblum JR et al (2008) Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Mod Pathol 21:943–949PubMedCrossRef
32.
Zurück zum Zitat Schouten J, McElgunn C, Waaijer R et al (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30:e57PubMedCentralPubMedCrossRef Schouten J, McElgunn C, Waaijer R et al (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30:e57PubMedCentralPubMedCrossRef
33.
Zurück zum Zitat Sellner L, Taylor G (2004) MLPA and MAPH: new techniques for detection of gene deletions. Hum Mut 23:413–419PubMedCrossRef Sellner L, Taylor G (2004) MLPA and MAPH: new techniques for detection of gene deletions. Hum Mut 23:413–419PubMedCrossRef
34.
Zurück zum Zitat Hömig-Hölzel C, Savola S (2012) Multiplex ligation-dependent probe amplification (MLPA) in tumor diagnostics and prognostics. Diagn Mol Pathol 21:189–206PubMedCrossRef Hömig-Hölzel C, Savola S (2012) Multiplex ligation-dependent probe amplification (MLPA) in tumor diagnostics and prognostics. Diagn Mol Pathol 21:189–206PubMedCrossRef
35.
Zurück zum Zitat Coffa J, Van de Berg J (2011) Analysis of MLPA data using novel software Coffalyser.NET by MRCHolland. In: Eldin AB (ed) Modern approaches to quality control. InTech, Rijeka, Croatia, pp 125–150 Coffa J, Van de Berg J (2011) Analysis of MLPA data using novel software Coffalyser.NET by MRCHolland. In: Eldin AB (ed) Modern approaches to quality control. InTech, Rijeka, Croatia, pp 125–150
36.
Zurück zum Zitat Coll-Mulet L, Santidrián AF, Cossials AM et al (2008) Multiplex ligation-dependent probe amplification for detection of genomic alterations in chronic lymphocytic leukemia. Br J Haematol 142:793–801PubMedCrossRef Coll-Mulet L, Santidrián AF, Cossials AM et al (2008) Multiplex ligation-dependent probe amplification for detection of genomic alterations in chronic lymphocytic leukemia. Br J Haematol 142:793–801PubMedCrossRef
37.
Zurück zum Zitat Berge EO, Knappskog S, Lillehaug JR et al (2011) Alterations of the retinoblastoma gene in metastatic breast cancer. Clin Exp Metastasis 28:319–326PubMedCentralPubMedCrossRef Berge EO, Knappskog S, Lillehaug JR et al (2011) Alterations of the retinoblastoma gene in metastatic breast cancer. Clin Exp Metastasis 28:319–326PubMedCentralPubMedCrossRef
38.
Zurück zum Zitat Berge EO, Knappskog S, Geisler S et al (2010) Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers. Mol Cancer 9:173PubMedCentralPubMedCrossRef Berge EO, Knappskog S, Geisler S et al (2010) Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers. Mol Cancer 9:173PubMedCentralPubMedCrossRef
39.
Zurück zum Zitat Tsachaki M, Ghiso J, Eftissiopoulos S (2008) BRI2 as a central protein involved in neurodegeneration. Biotechnol J 3:1548–1554PubMedCrossRef Tsachaki M, Ghiso J, Eftissiopoulos S (2008) BRI2 as a central protein involved in neurodegeneration. Biotechnol J 3:1548–1554PubMedCrossRef
40.
Zurück zum Zitat Vidal R, Frangione B, Rostagno A et al (1999) A stop codon mutation in the BRI gene associated with the familial British dementia. Nature 399:766–781CrossRef Vidal R, Frangione B, Rostagno A et al (1999) A stop codon mutation in the BRI gene associated with the familial British dementia. Nature 399:766–781CrossRef
41.
Zurück zum Zitat Fleischer A, Ayllon V, Rebollo A (2002) ITM2BS regulates apoptosis by inducing loss of mitochondrial membrane potential. Eur J Immunol 32:3498–3505PubMedCrossRef Fleischer A, Ayllon V, Rebollo A (2002) ITM2BS regulates apoptosis by inducing loss of mitochondrial membrane potential. Eur J Immunol 32:3498–3505PubMedCrossRef
42.
Zurück zum Zitat Fleischer A, Ayllon V, Dumouter L et al (2002) Proapoptotic activity of ITM2B(s), a BH3-only protein induced upon IL-2 deprivation which interacts with Bcl-2. Oncogene 21:3181–3189PubMedCrossRef Fleischer A, Ayllon V, Dumouter L et al (2002) Proapoptotic activity of ITM2B(s), a BH3-only protein induced upon IL-2 deprivation which interacts with Bcl-2. Oncogene 21:3181–3189PubMedCrossRef
43.
Zurück zum Zitat Fleischer A, Rebollo A (2004) Induction of p53-independent apoptosis by the BH3-only protein ITM2B. FEBS Lett 557:283–287PubMedCrossRef Fleischer A, Rebollo A (2004) Induction of p53-independent apoptosis by the BH3-only protein ITM2B. FEBS Lett 557:283–287PubMedCrossRef
44.
Zurück zum Zitat Devilder MC, Caderet E, Cherel M et al (1998) cDNA cloning, gene characterization and 13q14.3 chromosomal assignment of CHC1-L, a chromosome condensation regulator-like guanine nucleotide exchange factor. Genomics 54:99–106PubMedCrossRef Devilder MC, Caderet E, Cherel M et al (1998) cDNA cloning, gene characterization and 13q14.3 chromosomal assignment of CHC1-L, a chromosome condensation regulator-like guanine nucleotide exchange factor. Genomics 54:99–106PubMedCrossRef
45.
Zurück zum Zitat Latil A, Chene L, Mangin P et al (2003) Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion. Prostate 57:39–50PubMedCrossRef Latil A, Chene L, Mangin P et al (2003) Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion. Prostate 57:39–50PubMedCrossRef
46.
Zurück zum Zitat Lee S, Jeong J, Majewski T, Lee S, Jeong J, Majewski T et al (2005) Forerunner genes contiguous to Rb1 contribute to the development of in situ neoplasia. Proc Natl Acad Sci U S A 104:3732–3737 Lee S, Jeong J, Majewski T, Lee S, Jeong J, Majewski T et al (2005) Forerunner genes contiguous to Rb1 contribute to the development of in situ neoplasia. Proc Natl Acad Sci U S A 104:3732–3737
47.
Zurück zum Zitat Latil A, Morant P, Fournier G et al (2002) CHC1-L, a candidate gene for prostate carcinogenesis at 13q14.2, is frequently affected by loss of heterozygosity and underexpressed in human prostate cancer. Int J Cancer 99:689–696PubMedCrossRef Latil A, Morant P, Fournier G et al (2002) CHC1-L, a candidate gene for prostate carcinogenesis at 13q14.2, is frequently affected by loss of heterozygosity and underexpressed in human prostate cancer. Int J Cancer 99:689–696PubMedCrossRef
48.
Zurück zum Zitat Mentzel T (2000) Biological continuum of benign, atypical, and malignant mesenchymal neoplasms—does it exist? J Pathol 190:523–525PubMedCrossRef Mentzel T (2000) Biological continuum of benign, atypical, and malignant mesenchymal neoplasms—does it exist? J Pathol 190:523–525PubMedCrossRef
49.
Zurück zum Zitat Mertens D, Wolf S, Schroeter P et al (2002) Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia. Blood 99:4116–4121PubMedCrossRef Mertens D, Wolf S, Schroeter P et al (2002) Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia. Blood 99:4116–4121PubMedCrossRef
50.
Zurück zum Zitat Wolf S, Mertens D, Schaffner C et al (2001) B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate C-CLL gene on 13q14. Hum Mol Genet 10:1275–1285PubMedCrossRef Wolf S, Mertens D, Schaffner C et al (2001) B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate C-CLL gene on 13q14. Hum Mol Genet 10:1275–1285PubMedCrossRef
51.
Zurück zum Zitat Edelmann J, Holzmann K, Miller F et al (2012) High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. Blood 24:4783–4794CrossRef Edelmann J, Holzmann K, Miller F et al (2012) High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. Blood 24:4783–4794CrossRef
52.
Zurück zum Zitat Tyybäkinoja A, Vilpo J, Knuutila S (2007) High-resolution oligonucleotide array-CGH pinpoints genes involved in cryptic losses in chronic lymphocytic leukemia. Cytogenet Genome Res 118:8–12PubMedCrossRef Tyybäkinoja A, Vilpo J, Knuutila S (2007) High-resolution oligonucleotide array-CGH pinpoints genes involved in cryptic losses in chronic lymphocytic leukemia. Cytogenet Genome Res 118:8–12PubMedCrossRef
53.
Zurück zum Zitat Deyrup AT, Chibon F, Guillou L et al (2013) Fibrosarcoma-like lipomatous neoplasm. A reappraisal of so-called spindle cell liposarcoma defining a unique lipomatous tumor unrelated to other liposarcomas. Am J Surg Pathol 37:1373–1378PubMedCrossRef Deyrup AT, Chibon F, Guillou L et al (2013) Fibrosarcoma-like lipomatous neoplasm. A reappraisal of so-called spindle cell liposarcoma defining a unique lipomatous tumor unrelated to other liposarcomas. Am J Surg Pathol 37:1373–1378PubMedCrossRef
Metadaten
Titel
Atypical spindle cell lipoma: a clinicopathologic, immunohistochemical, and molecular study emphasizing its relationship to classical spindle cell lipoma
verfasst von
David Creytens
Joost van Gorp
Suvi Savola
Liesbeth Ferdinande
Thomas Mentzel
Louis Libbrecht
Publikationsdatum
01.07.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 1/2014
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-014-1568-8

Weitere Artikel der Ausgabe 1/2014

Virchows Archiv 1/2014 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …